Tenascin-C Expression in Ultrastructurally Defined Angiogenic and Vasculogenic Lesions

References

• Jones FS, Burgoon MP, Hoffman S, et al. A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA 1988; 85: 2186–2190
   PubMed Web of Science ®Google Scholar
• Erickson HP. Tenascin-C tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr Opinion Cell Biol. 1993; 5: 869–876
   PubMed Web of Science ®Google Scholar
• Grumet M, Hoffman S, Crossin KL, et al. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci USA 1985; 82: 8075–8079
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Mackie EJ, Adams Pearson C, et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131–139
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen, I: a monoclonal antibody as marker for tendon and muscle morphogenesis. J Cell Biol. 1984; 98: 1926–1936
   PubMed Web of Science ®Google Scholar
• Chiquet M, Fambrough DM. Chick myotendinous antigen, II: a novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol. 1984; 98: 1937–1946
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987; 105: 2569–2579
   PubMed Web of Science ®Google Scholar
• Kruse J, Keilhauer G, Faissner A, et al. The J1 glycoproteins novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature (London) 1985; 316: 146–148
   PubMed Web of Science ®Google Scholar
• Howeedy AA, Virtanen I, Laitinen L, et al. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest. 1990; 63: 71–79
   Google Scholar
• Tiitta O, Wahlstron T, Virtanen I, et al. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch [B] 1993; 63: 283–287
   Google Scholar
• Soini Y, Paakko P, Nuorva K, et al. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol. 1993; 100: 145–150
   PubMed Web of Science ®Google Scholar
• Sasano H, Nagura H, Watanabe K, et al. Tenascin expression in normal and abnormal human endometrium. Mod Pathol. 1993; 6: 323–326
   PubMedGoogle Scholar
• Van Eyken P, Sciot R, Desmet VJ, et al. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. J Hepatol. 1990; 11: 43–52
   PubMedGoogle Scholar
• Ibrahim SN, Lightner VA, Ventimiglia JB, et al. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol. 1993; 24: 982–989
   Google Scholar
• Shikata N, Oyaizu T, Andachi H, et al. Tenascin expression in normal human adult skin and skin appendage tumours. Virchows Arch. 1994; 424: 511–516
   PubMedGoogle Scholar
• Koukoulis GK, Gould VE, Bhattacharyya A, et al. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol. 1991; 22: 636–643
   PubMed Web of Science ®Google Scholar
• Webersinke G, Bauer H, Amberger A, et al. Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytes. Biochem Biophys Res Commun. 1992; 189: 877–884
   PubMedGoogle Scholar
• Ramadori G, Schwogler S, Veit TH, et al. Tenascin gene expression in rat liver and in rat liver cells: in vivo and in vitro studies. Virchows Arch [B] 1991; 60: 145–153
   Google Scholar
• Canfield AE, Schor AM. Evidence that tenascin and throm-bospondin-1 modulate sprouting of endothelial cells. J Cell Sci. 1995; 108: 797–809
   PubMed Web of Science ®Google Scholar
• Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 1995; 15: 907–914
   Google Scholar
• Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988; 107: 2757–2767
   PubMed Web of Science ®Google Scholar
• Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res. 1996; 56: 182–189
   PubMed Web of Science ®Google Scholar
• Schinella RA, Greco MA. Bacillary angiomatosis presenting as a soft-tissue tumor without skin involvement. Hum Pathol. 1990; 21: 567–569
   PubMedGoogle Scholar
• Zagzag D, Yang G, Seidman I, et al. Malignant epithelioid hemangioendothelioma arising in an intramuscular lipoma. Cancer 1993; 71: 764–768
   PubMedGoogle Scholar
• Kostianovsky M, Greco MA. Angiogenic process in bacillary angiomatosis. Ultrastruct Pathol. 1994; 18: 349–355
   PubMed Web of Science ®Google Scholar
• Rosai J, Summer WH, Kostianovsky M, et al. Angiosarcoma of the skin: a clinicopathologic and fine structural study. Hum Pathol. 1976; 7: 83–109
   PubMed Web of Science ®Google Scholar
• Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989; 5: 71–92
   PubMedGoogle Scholar
• Mackie EJ, Chiquet-Ehrismann R, Adams Pearson C, et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 1987; 84: 4621–4625
   PubMed Web of Science ®Google Scholar
• Tiitta O, Sipponen P, Gould V, et al. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach. Virchows Arch. 1994; 425: 369–374
   PubMedGoogle Scholar
• Dvorak HF. Tumors: Wounds that do not heal. N Engl J Med. 1986; 25: 1650–1655
   Google Scholar
• Natali PG, Nicotra MR, Bartolazzi A, et al. Expression and production of tenascin in benign and malignant lesions of melanocytic lineage. Int J Cancer 1990; 46: 586–590
   PubMedGoogle Scholar
• Weiss WS, Enzinger FM. Epitheliod hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982; 50: 970–981
   PubMed Web of Science ®Google Scholar
• Kostianovsky M, Lamy Y, Greco MA. Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. Ultrastruct Pathol. 1992; 16: 629–640
   PubMed Web of Science ®Google Scholar
• Sriramarao P, Mendler M, Bourdon MA. Endothelial cell attachment and spreading on human tenascin is mediated by a 2(i1 and α v β3 integrins. J Cell Sci. 1993; 105: 1001–1012
   PubMed Web of Science ®Google Scholar
• Pietro AL, Anderson-Fisone C, Crossin KL. Characterization of multiple adhesive and counter adhesive domains in the extracellular matrix protein cytotactin. J Cell Biol. 1992; 119: 663–678
   PubMedGoogle Scholar
• Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin α v β3 for angiogenesis. Science (Washington, DC) 1994; 264: 596–597
   Google Scholar
• Wagner RC. Endothelial cell embryology and growth. Adv Microcirc. 1980; 9: 45–75
   Google Scholar
• Risau W, Sariola H, Zerwes G-H, et al. Vasculogenesis and angiogenesis in embryonic-stem-cell derived embryoid bodies. Development 1988; 102: 471–478
   PubMed Web of Science ®Google Scholar
• Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288: 551–556
   PubMed Web of Science ®Google Scholar
• Konerding MA, Van Ackern C, Steinberg F, . Combined morphological approaches in the study of network formation in tumor angiogenesis. Angiogenesis, R Steiner, PB Weisz, R Lanzer, et al. Birkhauser, BaselSwitzland 1992; 40–58
   Google Scholar
• Sharifi BG, LaFleur DW, Pirola CJ, et al. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem. 1992; 267: 23910–23915
   PubMedGoogle Scholar
• Adams Pearson CA, Pearson D, Shibahara S, et al. Tenascin: cDNA cloning and induction of TGF-β. EMBO J. 1988; 7: 2677–2981
   Google Scholar
• Meiners S, Marone M, Rittenhouse JL, et al. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev Biol. 1993; 160: 480–493
   PubMed Web of Science ®Google Scholar
• Brodkey JA, Laywell ED, O'Brien TF, et al. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg. 1995; 82: 106–112
   PubMedGoogle Scholar
• Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (London) 1994; 371: 674–680
   PubMed Web of Science ®Google Scholar
• End P, Panayotou G, Entwistle A, et al. Tenascin: a modulator of cell growth. Eur J Biochem. 1992; 209: 1041–1051
   PubMedGoogle Scholar